IGNT-Ingen Technologies, Inc.

[rob111]

This stock is set to explode today. Here are some details of the cIngen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing US and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufacturers all of its respiratory products in the United States. There are 32 million US patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.
ompany:

[RAZOR11]

HEY ALL IGNT HAD GREAT VOLUME ON FRI CLOSEING @ 118.4 MIL AND UP 11.7%!!! RSI LINE IS BULLISH @51.48 AND MAC D LINE IS EVEN WITH THE SIGNAL LINE AND HAS BEEN SINCE JULY!!. NEXT RESISTACE IS .0047. IMO THIS STOCK IS GOING TO HAVE GREAT VOLUME AND PRICE INCREASES THROUGHOUT THE WEEK. THIS STOCK IS ON MY RADAR AND IM LOOOKING TO MAKE A PROFIT!!!!

[trading_guy]

YUCAIPA, Calif., Oct. 26, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries announced today that the company has reported an increase in first quarter sales for 2009 as compared to the same quarter in 2008. Gross profits represented 63% gross margins.


Related Quotes
Symbol Price Change
IGNT.PK 0.0038 0.0000


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}
Ingen reported gross sales of $106,483 in the quarter ended August 31, 2009. This represented an increase from sales of $987 in the quarter ended August 31, 2008. The sales were further sparked by the introduction of an "all-in-one" Oxyview Nasal Cannula unit that includes a cannula with the Oxyview flow meter included. Additional capital also enabled the company to increase its advertising and marketing of the Oxyview products. Ingen anticipates that sales of Oxyview will increase from the current quarter's sales as the company expands its sales channels. The total cost of sales was $38,804 in the quarter ended August 31, 2009 and the gross profit was $67,679 (a gross margin of 63.6%).



"We are seeing the initial results of the introduction of our Oxyview Nasal Cannula. There is still hard work ahead of us, and our management is focused on distribution and sales. Our immediate focus being ISO certification and CE Mark requirements that we will complete in late December-2009. Between now and then we are closing distribution for export of our products, and reorganizing our domestic distribution. The home oxygen patients are the bulk of our sales at this time, and this is a good indication that they want and need this product. We expect an increased response for our new Oxyview Nasal Cannula upon its introduction to the annual Chest Physicians meeting at the end of this month, along with Medical and Arab Health conventions in the near future. Targeting these respiratory physicians, management and home oxygen suppliers will increase sales significantly," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board

[trading_guy]

YUCAIPA, Calif., Oct. 30, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the company has hired Anton & Chia, LLP as the new auditing firm after dismissing Child, Van Wagoner and Bradshaw on Wednesday of this week.


Related Quotes
Symbol Price Change
IGNT.PK 0.00 0.00


{"s" : "ignt.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}
The Irvine-California based Anton & Chia's team of professionals consist of certified public accountants that are able to assist Ingen with the 10-KSB ending May 31, 2009 and future filings. This firm has over 40 years of experience working with small to middle market companies and understands Ingen's needs. Anton & Chia are licensed CPAs in the following states: California, Colorado, Florida and New York and have a professional staff that are fluent in speaking and writing Mandarin, Cantonese, Italian, and Spanish. As specialists in the realm of public company accounting and reporting, the professionals of Anton & Chia, LLP go to great lengths to ensure the accuracy and timeliness of required financial reporting, compliance and transaction-related issues for our public clients. With the immediate needs of Ingen, Anton & Chia will assist the company in preparing for and meeting obligations in the increasingly complex regulatory environment of public companies in order to comply with rules of the U.S. Securities and Exchange Commission (SEC) and obligations promulgated by the Sarbanes-Oxley Act of 2002.



"We found a firm that can meet our filing schedule. Our legal and accounting team is working very close with the SEC and the new auditors to complete and file the 10-KSB ending May 31, 2009 and subsequent 10-Q's to bring current our filing obligations," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

[mickymoose99]

Pinnacle Digest: Looking For Shareholder Opinions On Ingen Technologies' Latest News

Nov 02, 2009 (M2 PRESSWIRE via COMTEX) -- is a performance-driven online financial magazine and social network with a proven track record. After Friday's news from Ingen Technologies, Inc. (Pink Sheets:IGNT) announcing that the company has hired Anton & Chia, LLP as the new auditing firm after dismissing Child, Van Wagoner and Bradshaw on Wednesday of this week, our team is inviting all shareholders to their exclusive investor controlled forum. Our staff and members have requested that all Ingen shareholders join our community and share their thoughts on the company, its development and future outlook. One of the most important aspects when we research for new investments is to understand the sentiment of the current shareholders; that is why we have released this announcement - we want to know your opinion.
Join The Ingen Investor Discussion Here:

Join PinnacleDigest.com to

Find out if Ingen makes it as a Pinnacle Featured Company,

Chat with other shareholders invested in Ingen,

Explain to our investor community what differentiates this company,

Connect with investors and professionals in the equity markets,

Meet the thousands of investors who have already become members of the Pinnacle community.

PinnacleDigest.com is an investment club comprised of over 15,000 members. We use all of our member's insight when selecting our next investment opportunity. Your membership is free - join today.

PinnacleDigest.com has no vested interest in the company mentioned herein. The company mentioned in this release has not compensated PinnacleDigest.com in any form to disseminate this release.

This source of information is from an unbiased perspective. If you wish to become a member of you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.

This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.

All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.

Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.

You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to .




(C)1994-2009 M2 COMMUNICATIONS
-0-

[Chuck.W]

Thanks for the good news. IGNT looks like a great pick this week. Keep this one on the radar. Also watching TCHH, EVRN.

[mickymoose99]

IGNT
Keep an eye on it , IGNT came out with news friday after the close and this morning .
i see this getting into position to make a nice run .
its in the bearish range at 36.19
prev close was 0.0029
MacD Line is even
has the potential for a quick flip

[Chuck.W]

Ingen CEO Live Radio Interview Tomorrow With The Money Channel
CEO Discusses Projections for 2010 of $10M in Sales

Press Release
Source: Ingen Technologies, Inc.
On 10:15 am EST, Monday November 2, 2009

YUCAIPA, Calif., Nov. 2, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink Sheets:IGNT - News), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the CEO, Scott Sand, will discuss conservative projections for 2010 tomorrow, Tuesday November 3, 2009, at 11:24AM on The Money Channel's American Scene Radio with host Steve Crowley.



A growing elderly population, increase in home oxygen therapy and surgeries and an increase in Chronic Obstructive Pulmonary Diseases in the USA will result in demand for better efficiency and cost reductions in medical care. The elderly population in the USA age 75 and older in 2010 is expected to be almost 19M. In 2015 it is expected to increase to 20M and over the next 30 years will more than double. The Oxyview and Oxyview Nasal Cannula improves home oxygen therapy and reduces supplier costs by decreasing unnecessary service calls, thus reducing government expenditures related to treating COPD.



The World Health Organization (WHO) estimates that COPD as a single cause of death in the world shares 4th and 5th places with HIV/AIDS (after coronary heart disease, cerebrovascular disease and acute respiratory infection). COPD is the fourth leading cause of death in the U.S. and is projected to be the third leading cause of death for both males and females by the year 2020. It is estimated that there may currently be 16 million people in the United States currently diagnosed with COPD, and that there may be as many as an additional 14 million or more in the United States still undiagnosed, as they are in the beginning stages and have little to minimal symptoms and have not sought health care yet. About 1.5 million emergency department visits by adults 25 and older were made for COPD in 2000. The total estimated cost of COPD in 2002 was $32.1 billion. $18 billion were direct costs. $14.1 billion were indirect cost, and it is estimated that the total cost of managing COPD in 1998, physicians, medications, hospital and nursing care, etc., exceeded 15 billion dollars in the United States.



With proper marketing, advertising, branding, distribution and direct sales; Ingen expects to generate $10M in sales. These numbers are based on assumptions and recent historical trends with the company's increase in sales and market acceptance. The ISO 13485 Certification expected in December 2009 will instantly result in large export shipments of the Oxyview and Oxyview Nasal Cannula products. In addition, the company has signed marketing contracts with various firms to activate an immediate direct sales program to oxygen providers, suppliers and COPD support groups in the USA. The sales in 2010 will represent approximately less than 1% of the US market in oxygen cannula sales.



With the new manufacturing revisions, manufacturing costs will decrease approximately by 50%, while this new revision increases quality and efficiency in the manufacture of Oxyview and the Oxyview Nasal Cannula. The prior sales margins of 63% will remain the same while the company passes these manufacturing savings directly to its distribution as an incentive to better compete with the competition.



"With the new auditors in place, and near completion of the required SEC filings, the management is focused on increasing sales and distribution of the Oxyview and Oxyview Nasal Cannula; while we continue to finalize ISO and GSA in the next 2 months. The GSA application was submitted in September-2009 and GSA has informed us that they have undergone internal changes and would respond in the next 30 days. GSA increases our sales in to the VA hospitals, while the ISO certification opens huge doors for exporting our products globally," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.

[trading_guy]

I think this stock is gonna do extremly well today imo.... Also keep your eyes on EFLN, NTMI, TCHH, EVRN for possible run today!!!

[mickymoose99]

IGNT
Starting to heat up +16%
RSI Line is @ 42.72 curving up looking good
volume is moving should go over the 10 day avg of 56 million as of now its at 55 million
bids are building .0028 as of now
staring to heat up,

[mickymoose99]

IGNT
Its now up 20%
RSI Line up to 44.14 and rising
looking good , setting it self up
for a poss strong run

[mickymoose99]

IGNT
congrates to all on IGNT
+ 36%
RSI Line 49.21 and still rising looks good
volume way over the 10 day avg

[mickymoose99]

IGNT
Yesterdays open 0.0029
Close 0.0033
+ 32%
RSI Line 48.03 and rising
MacD even
Slope curving up
charts look possitive
im looking for IGNT to have another good day

[Chuck.W]

IGNT Ingen Technologie, INC.
Good volume yesterday at 89,495,632.
Charts look good. RSI line heading towards bullish.
Looking for another great day today for this one.IMO.
Interview today from CEO Scott Sand to discuss conservative projections
for 2010 on The Money Channel. Good luck to all.

[RAZOR11]

IGNT HAD A GREAT DAY YESTERDAY!! THIS STOCK HAD SOME GREAT VOLUME 89 MIL AT THE EOD AND THE PRICE WAS DRIVEING UP WITH A NEW HOD!! CHARTS LOOKS GOOD ON THIS STOCK. RSI LINE HEADING NORTH AND APROACHING BULLISH. MAC D LINE HAS BEEN RUNNING EVEN WITH THE SIGNAL LINE FOR A WHILE. WE BROKE THROUGH THE 20 DAY MA LINE AND .004 IS OUR NEXT RESISTANCE AND ALSO THE 50 MA. IMO THIS STOCK IS GOING TO HAVE ANOTHER GREAT DAY WITH MORE PRICE INCREASES TODAY AND THROUGHOUT THE WEEK. LOOKS LIKE A GOOD STOCK TO GET INTO AND MAKE SOME PROFITS!!! ALSO KEEEP AN EYE ON TCHH,EVRN,

[mickymoose99]

< Back

Wall Street News Alert: Stock on the Move: HearAtLast Holdings -- November 3, 2009

Weston, FLA, Nov 03, 2009 (M2 PRESSWIRE via COMTEX) -- Wall Street News Alert's "stocks to watch" this morning are: HearAtLast Holdings, Inc. (OTC: HRAL), Ingen Technologies, Inc. (OTC: IGNT), Ironwood Gold Corp. (OTCBB: IROG) and Aftersoft Group, Inc. (OTCBB: ASFG).
Yesterday after the markets closed, HearAtLast Holdings, Inc. (OTC: HRAL) issued a press release announcing that the Company has posted its amended earnings report on pinksheets.com. The posted earnings reflect the fiscal second quarter period covering 04/01/2009 - 06/30/2009. HearAtLast is a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market.

The Company recorded gross profits of USD $382,463 for Q2 of FY2009, a 19% increase compared to Q2 FY2008 gross profits of US $320,564. Operating expenses for the same period Q2 of FY2009 decreased 53% to US $738,403 compared to Q2 FY2008 of US $2,051,150. HearAtLast also reduced their debt ratio. The debt ratio is the proportion of a firm's total assets that are being financed with borrowed funds.

"We are very pleased with the direction of our company. We expect gross profits from all stores to continue to increase while operating expenses and debt ratio decline due to aggressive restructuring and reduced overheads. Despite the reduction in overhead, clinic performance has been enhanced as the companies' clinic base has entered year two of their operations. We still maintain our focus on becoming Canada's largest network of hearing stores," stated Matthew Sacco, President and CEO.

On October 22, 2009, the company reported that its game plan is to become Canada's largest distribution channel of Hearing Devices and related products and services under its hearing store model co-located within select Wal-Marts in Canada.

The stock closed yesterday at just under Six cents a share.

To receive FREE Mobile Stock Alerts formatted especially for your cell phone, text the word "press" in the subject line to 68494.

For more information, please visit and you can also follow Wall Street News Alerts on Twitter at

Ingen Technologies, Inc. (OTC: IGNT) up 32% on 89.4 million shares traded.

On Nov 2, 2009 Ingen Technologies, Inc. recently announced that the CEO, Scott Sand, will discuss conservative projections for 2010 tomorrow, Tuesday November 3, 2009, at 11:24AM on The Money Channel's American Scene Radio with host Steve Crowley.

A growing elderly population, increase in home oxygen therapy and surgeries and an increase in Chronic Obstructive Pulmonary Diseases in the USA will result in demand for better efficiency and cost reductions in medical care. The elderly population in the USA age 75 and older in 2010 is expected to be almost 19M. In 2015 it is expected to increase to 20M and over the next 30 years will more than double. The Oxyview and Oxyview Nasal Cannula improves home oxygen therapy and reduces supplier costs by decreasing unnecessary service calls, thus reducing government expenditures related to treating COPD.

The World Health Organization (WHO) estimates that COPD as a single cause of death in the world shares 4th and 5th places with HIV/AIDS (after coronary heart disease, cerebrovascular disease and acute respiratory infection). COPD is the fourth leading cause of death in the U.S. and is projected to be the third leading cause of death for both males and females by the year 2020. It is estimated that there may currently be 16 million people in the United States currently diagnosed with COPD, and that there may be as many as an additional 14 million or more in the United States still undiagnosed, as they are in the beginning stages and have little to minimal symptoms and have not sought health care yet. About 1.5 million emergency department visits by adults 25 and older were made for COPD in 2000. The total estimated cost of COPD in 2002 was $32.1 billion. $18 billion were direct costs. $14.1 billion were indirect cost, and it is estimated that the total cost of managing COPD in 1998, physicians, medications, hospital and nursing care, etc., exceeded 15 billion dollars in the United States.

About Ingen: Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the US, and $8 billion globally.

Ironwood Gold Corp. (OTCBB: IROG) up 58.6% on 372,000 shares traded.

On Oct 30, 2009 Ironwood Gold Corp. recently announced it has signed an acquisition agreement with Ironwood Mining Corp., and related parties for 100% right, title and interest in and to certain mineral claims known as the Cobalt Canyon Gold Project in Nevada. The agreement includes consideration of both share and cash payments in exchange for said title.

The Cobalt Canyon project is located at an elevation of about 6,000 feet in the Caliente mining district of southeastern Nevada, in Lincoln County on the east flank of the Chief Range about 115 miles northeast of Las Vegas and 5 miles north of the town of Caliente. The project data includes an independently authored 2008 N.I. 43-101 compliant report which offers the opinion that Cobalt Canyon appears to have potential for 1.5 million ounces of gold -- and possibly considerably more -- as either an open-pit or underground target. Given the high grades in some samples -- up to 1.16 opt Au, Cobalt Canyon appears to have potential for an underground mine. If mineralization is also disseminated in wall rocks around the mineralized structures as suggested by several samples, the property may also hold tonnages and grades that could support an open-pit mine.

Ironwood Gold Corp. plans to undertake an exploration program consisting of (but not limited to) additional claims, mapping and prospecting, geochemical sampling, analysis of ore specimens and selective induced potential surveys of geologically identified targets, identification of drill targets, and an initial program of 5,000 feet of core drilling in order to further the development of the project into a production phase.

Ironwood Gold Corp. is a mineral exploration and development company building a portfolio of prospective properties containing known deposits of strategic precious metals in politically stable, mining-friendly North American districts with recognized production histories.

Aftersoft Group, Inc. (OTCBB: ASFG) up 50% on 212,000 shares traded.

On Oct 31, 2009 Aftersoft Network N.A., Inc. a wholly owned subsidiary of Aftersoft Group, Inc. a leading provider of business automation and ecommerce solutions for the automotive aftermarket, recently announced the general release of OpenWebs, Version 5, (OW V5), completed after months of design and development. This latest version has been enhanced to use both Microsoft's .NET and Ajax (asynchronous JavaScript +XML) technologies. These changes have enhanced the system speed for inventory lookups while simultaneously requiring fewer page refreshes.

OpenWebs is an ecommerce platform used by buyers and sellers in the automotive aftermarket to facilitate both system to system and browser to system electronic ordering. OpenWebs includes modules for business to business (B2B) as well as business to consumer (B2C) electronic commerce. OpenWebs is currently deployed at over thirty five tire & parts distributors and is connected to thousands of buyer service shops, jobbers and tire stores.

Aftersoft Group, Inc. is a supplier of business and ERP supply chain management solutions to automotive parts manufacturers, distributors and retailers. Aftersoft Group provides the automotive aftermarket with a combination of business management systems, information products, and online services that together deliver benefits for all parties involved in the timely repair of a vehicle.

Market Commentary: The Institute for Supply Management said its index of national factory activity rose to 55.7 in October from 52.6 in September. The median forecast of 74 economists surveyed by Reuters was for a reading of 53.

Let Wall Street News Alert help advertise for your company using our effective awareness campaigns. If you're Interested in telling your story, we can help. Contact us at

WSNA's email alert service is free to those investors who sign up on the WSNA home page. The alert service is designed to notify investors of often-overlooked stocks. Subscribers are introduced to Special Situation companies that have the potential of showing increased activity. The Wall Street News Alert home page has experienced over 200 million hits. To subscribe to this free service, visit the Wall Street News Alert home page at .

*** It has come to the attention of Wall Street News Alert (WSNA), that various persons or companies distribute faxes bearing similar names to Wall Street News Alert. Wall Street News Alert is not affiliated with faxes bearing names such as: Wall Street Stock Alert, Wall Street Investor Alert, Wall Street News Alert or any other fax using various combinations of the generic words Wall Street.***

Wall Street News Alert is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSCF is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSCF profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSCF and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSCF research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSCF disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSCF is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSCF profiled stocks.

This profile is not without bias, and is a paid release. WSCF has been compensated for dissemination of company information on behalf of one or more of the companies mentioned in this release. WSCF has not been compensated for current services performed for HearAtLast Holdings, Inc. (OTC: HRAL). However, WSCF may receive compensation for future services. WSCF was previously compensated for services rendered in 2008 & 2007. Any additional compensation will be disclosed at such time that WSCF is aware of a clients desire to extend the original services. WSCF may have received shares of a company profiled in this release prior to the dissemination of the information in this release. WSCF may immediately sell some or any shares in a profiled company held by WSCF and may have previously sold shares in a profiled company held by WSCF. WSCF's services for a company may cause the company's stock price to increase, in which event WSCF would make a profit when it sells its stock in a company. In addition, WSCF's selling of a company's stock may have a negative effect on the market price of the stock.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or "projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WSCF undertakes no obligation to update such statements.

CONTACT: Wall Street News Alert e-mail: WWW:

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at on the world wide web. Inquiries to .




(C)1994-2009 M2 COMMUNICATIONS
-0-

[mickymoose99]

MY LITTLE BIRD JUST FLEW BACK FROM ignt WINDOWS HE SAID BIG NEWS COMING AT THE CLOSE

[Chuck.W]

IGNT Ingen Technologies, INC.

Stocks trading with good volume again today. Volume up around 10day moving avg. Trading like possible news after close today.IMO. Should be another good week for this one. Keep on the radar. Good luck to all

[mickymoose99]

Ingen Announces Projections of $10M in Sales for 2010

YUCAIPA, Calif., Nov 3, 2009 (GlobeNewswire via COMTEX) -- Ingen Technologies, Inc. (Pink Sheets:IGNT), a leading global Medical Device Manufacturer focused on the $4B Respiratory market with their Oxyview products for the growing aging population and emerging markets for Home (DME), Hospital and Aviation industries, announced today that the CEO, Scott Sand, discussed conservative projections for 2010 on The Money Channel's American Scene Radio with host Steve Crowley this past Tuesday.
A growing elderly population, increase in home oxygen therapy and surgeries, and an increase in Chronic Obstructive Pulmonary Diseases in the USA will result in demand for better efficiency and cost reductions in medical care. The elderly population in the USA age 75 and older in 2010 is expected to be almost 19M. In 2015 it is expected to increase to 20M, and over the next 30 years will more than double. The Oxyview and Oxyview Nasal Cannula improves home oxygen therapy and reduces supplier costs by decreasing unnecessary service calls, thus reducing government expenditures related to treating COPD.

The World Health Organization (WHO) estimates that COPD as a single cause of death in the world shares 4th and 5th places with HIV/AIDS (after coronary heart disease, cerebrovascular disease and acute respiratory infection). COPD is the fourth leading cause of death in the U.S. and is projected to be the third leading cause of death for both males and females by the year 2020. It is estimated that there may currently be 16 million people in the United States currently diagnosed with COPD, and that there may be as many as an additional 14 million or more in the United States still undiagnosed, as they are in the beginning stages and have little to minimal symptoms and have not sought health care yet. About 1.5 million emergency department visits by adults 25 and older were made for COPD in 2000. The total estimated cost of COPD in 2002 was $32.1 billion. $18 billion were direct costs. $14.1 billion were indirect cost, and it is estimated that the total cost of managing COPD in 1998, physicians, medications, hospital and nursing care, etc., exceeded 15 billion dollars in the United States.

With proper marketing, advertising, branding, distribution and direct sales, Ingen expects to generate $10M in sales. These numbers are based on assumptions and recent historical trends with the company's increase in sales and market acceptance. The ISO 13485 Certification expected in December-2009 will instantly result in large export shipments of the Oxyview and Oxyview Nasal Cannula products. In addition, the company has signed marketing contracts with various firms to activate an immediate direct sales program to oxygen providers, suppliers and COPD support groups in the USA. The sales in 2010 will represent approximately less than 1% of the US market in oxygen cannula sales.

With the new manufacturing revisions, manufacturing costs will decrease approximately by 50%, while this new revision increases quality and efficiency in the manufacture of Oxyview and the Oxyview Nasal Cannula. The prior sales margins of 63% will remain the same while the company passes these manufacturing savings directly to its distribution as an incentive to better compete with the competition.

"With the new auditors in place, and near completion of the required SEC filings, the management is focused in increasing sales and distribution of the Oxyview and Oxyview Nasal Cannula; while we continue to finalize ISO and GSA in the next 2 months. The GSA application was submitted in September-2009 and GSA has informed us that they have undergone internal changes and would respond in the next 30 days. GSA increases our sales in to the VA hospitals, while the ISO certification opens huge doors for exporting our products globally," stated Scott R. Sand, Chief Executive Officer and Chairman of the Board.









About Ingen: Ingen is an established medical device manufacturer with an emerging new medical product line for the respiratory market worth an estimated $4 Billion in the U.S., and $8 billion globally. The company introduced Oxyview into the respiratory market in late 2007 after securing U.S. and Foreign Patents and successful licensing with the Food & Drug Administration, and has commenced domestic and global distribution with manufacture representative organizations, and OEM partners. In 2009, the company introduced the new Oxyview Nasal Cannula for adults, children and infants. In addition to selling its respiratory products within the global medical industry, the company is selling the same products within other industries that include aviation, automotive, emergency response, military and government transportation. The company holds a Device Manufacturing License with the State of California, Department of Public Health, Food and Drug Branch as it manufactures all of its respiratory products in the United States. There are 32 million U.S. patients with Chronic Obstructive Pulmonary Disease (COPD), and 600 million patients worldwide. Ingen Technologies is now the largest manufacturer of in-line gravity-independent oxygen flow meters.

The Ingen Technologies, Inc. logo is available at

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

This news release was distributed by GlobeNewswire,

SOURCE: Ingen Technologies, Inc.


By Staff

CONTACT: CONTACT: Ingen Technologies, Inc.
Jeff Morgan
909-790-7180


(C) Copyright 2009 GlobeNewswire, Inc. All rights reserved.
-0-

INDUSTRY KEYWORD: Healthcare & Medical Services
SUBJECT CODE: MEDICAL
Company Announcement

[fordf250]

stockhideout.com has this stock on the scan alerts for tomorrows market. ive been watching this stock for about a week now, the company is looking further in medical evaluation.. i believe that this companie has wat it takes to make it in the dollars. been hearing alot of commotion, gunna ask up in the am.